ML

Michael Lee

Board Member at Fate Therapeutics

Mr. Lee is a co-founder and portfolio manager at Redmile Group, LLC, a healthcare-focused investment firm based in San Francisco and New York. Prior to Redmile, he worked as a biotechnology investor at Steeple Capital, and before that at Welch Capital Partners and Prudential Equity Group. Mike holds a B.S. in Molecular and Cellular Biology from the University of Arizona.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Fate Therapeutics

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.


Industries

Employees

201-500

Links